20/20 BiolabsAIDX

13F holders, Q2 2026 (June 30)
15holders +8
10new positions
2sold out
1famous investor
$0.55avg. 13F price*

At the end of Q2 2026, 15 institutions reported holding 20/20 Biolabs Inc. (AIDX) in their 13F filings, up 8 from Q1 2026. 10 opened new positions and 2 sold out. The largest holders were Cresset Asset Management, LLC ($132K), HRT Financial LP ($49K) and Vanguard Fiduciary Trust Co. ($29K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
20/20 Biolabs Inc.
CUSIP
90138K101
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q1 2026: 7Q1 2026Q2 2026: 15Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions10$152K
Exits2$21K

All 13F filers, Q1 2026 → Q2 2026: 284,138 shares bought and 43,943 shares sold, net +240,195 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

Cresset Asset Management, LLC 0.00% Reduce -9.2% 240,122 $132K
HRT Financial LP 0.00% New 89,273 $49K
Vanguard Fiduciary Trust Co. 0.00% New 52,087 $29K
Geode Capital Management, LLC 0.00% New 49,141 $27K
Atlantic Union Bankshares Corp 0.00% New 35,099 $19K
Vanguard Capital Management LLC 0.00% New 24,530 $13K
Citadel Advisors 0.00% Add +43.0% 23,205 $13K
Bank of America Corp. 0.00% New 13,024 $7K
Susquehanna International Group, LLP 0.00% New 10,014 $6K
McDonald Partners LLC 0.00% New 2,800 $2K
Signaturefd, LLC 0.00% New 767 $422
Morgan Stanley 0.00% New 283 $156
Allworth Financial LP 0.00% Add +473.3% 172 $95
Toth Financial Advisory Corp. 0.00% Reduce -36.3% 100 $55
UBS Group AG 0.00% Reduce -100.0% 3 $2

"% of holder's portfolio" is AIDX's weight in each manager's 13F, not the share of 20/20 Biolabs Inc. the manager owns.